Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 8/20 | 0.35 |
| ▸ | CES1 | P23141 | 5/20 | 0.34 |
| ▸ | CES2 | O00748 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL9495552 | 1.00 | SLC22A1 (0.40) | SLC22A1THRBSLC22A2FAAHCES1 | |
| Tetrabuthylammonium SCHEMBL7700891 | 0.97 | SLC22A1 (0.38) | SLC22A1THRBSLC22A2FAAHCES1 | |
| SCHEMBL1701168 | 0.97 | SLC22A1 (0.38) | SLC22A1THRBSLC22A2FAAHCES1 | |
| Tetrabuthylammonium SCHEMBL4934068 | 0.93 | SLC22A1 (0.43) | SLC22A1SLC22A2FAAHCES1CES2 | |
| Tetrapropylammonium SCHEMBL1701184 | 0.90 | THRB (0.41) | SLC22A1THRB | |
| Tetrabuthylammonium SCHEMBL10527770 | 0.86 | SLC22A1 (0.46) | SLC22A1SLC22A2FAAHCES1CES2 | |
| Cetrimonium SCHEMBL10869268 | 0.86 | DNM1 (0.46) | THRBFAAHCES1CES2KMT2A | |
| Tetrabuthylammonium SCHEMBL10749753 | 0.85 | THRB (0.59) | SLC22A1THRBSLC22A2FAAHCES1 | |
| Bromide SCHEMBL7939227 | 0.83 | DNM1 (0.46) | MEN1KMT2A | |
| SCHEMBL27556766 | 0.82 | THRB (0.55) | SLC22A1THRBSLC22A2FAAHCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240166658-A1 | PORPHYRIN DERIVATIVES AND USES THEREOF | UNIVERSITY OF TASMANIA (AU) | 2024-05-23 | — | — | US | disclosed |
| EP-4298101-A1 | PORPHYRIN DERIVATIVES AND USES THEREOF | University Of Tasmania (AU) | 2024-01-03 | — | — | EP | disclosed |
| WO-2022178593-A1 | PORPHYRIN DERIVATIVES AND USES THEREOF | UNIVERSITY OF TASMANIA (AU) | 2022-09-01 | — | — | WO | disclosed |
| US-8613214-B2 | Apparatus and method for determining analyte content in a fluid | ORONO SPECTRAL SOLUTIONS, INC. (US) | 2013-12-24 | — | — | US | disclosed |
| US-20110162441-A1 | APPARATUS AND METHOD FOR DETERMINING ANALYTE CONTENT IN A FLUID | ORONO SPECTRAL SOLUTIONS, INC. (US) | 2011-07-07 | — | — | US | disclosed |
| US-7759401-B2 | Nanoporous and microporous solvogels and nanolatexes by microemulsion polymerization | EASTERN MICHIGAN UNIVERSITY (US) | 2010-07-20 | — | — | US | disclosed |
| US-20090176915-A1 | NANOPOROUS AND MICROPOROUS SOLVOGELS AND NONOLATEXES BY MICROEMULSION POLYMERIZATION | EASTERN MICHIGAN UNIVERSITY | 2009-07-09 | — | — | US | disclosed |
| EP-1146956-B1 | MICROEMULSIONS CONTAINING WATER AND HYDROFLUOROETHERS | 3M INNOVATIVE PROPERTIES CO (US) | 2004-02-11 | — | — | EP | disclosed |
| EP-1146956-A1 | MICROEMULSIONS CONTAINING WATER AND HYDROFLUOROETHERS | 3M Innovative Properties Company (US) | 2001-10-24 | — | — | EP | disclosed |
| US-6127430-A | CLEANING AGENTS, SOLVENTS, AND DELIVERY SYSTEMS; MAY ALSO CONTAIN A FLUORINATED SURFACTANT OR A MIXTURE OF SUCH AND MAY ALSO CONTAIN A COSURFACTANT AND/OR COSOLVENT | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-10-03 | — | — | US | disclosed |
| WO-2000035571-A1 | MICROEMULSIONS CONTAINING WATER AND HYDROFLUOROETHERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-06-22 | — | — | WO | disclosed |
| EP-0158875-B1 | CHIRAL-RHODIUM-DIPHOSPHINE COMPLEXES FOR ASYMETRIC HYDROGENATIONS | F. HOFFMANN-LA ROCHE AG (CH) | 1989-12-13 | — | — | EP | disclosed |
| EP-0115446-B1 | METAL FILM IMAGING STRUCTURE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-04-05 | — | — | EP | disclosed |
| US-4652657-A | Chiral rhodium-diphosphine complexes | HOFFMANN-LA ROCHE INC. (US) | 1987-03-24 | — | — | US | disclosed |
| EP-0158875-A2 | Chiral-rhodium-diphosphine complexes for asymetric hydrogenations | F. HOFFMANN-LA ROCHE AG (CH) | 1985-10-23 | — | — | EP | disclosed |
| US-4511641-A | Metal film imaging structure | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-04-16 | — | — | US | disclosed |
| EP-0115446-A2 | Metal film imaging structure | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1984-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166658-A1 | PORPHYRIN DERIVATIVES AND USES THEREOF | PFAS, PCBP1, FGR | SLC22A1 1369/4885THRB 889/4885SLC22A2 1348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.